Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes.
The facilitative glucose transporter, GLUT4, mediates insulin-stimulated glucose uptake in adipocytes and muscles, and the participation of GLUT4 in the pathogenesis of various clinical conditions associated with obesity, visceral fat accumulation and insulin resistance has been proposed. Glucose uptake by some members of the GLUT family, mainly GLUT1, is inhibited by flavonoids, the natural polyphenols present in fruits, vegetables and wine. Therefore it is of interest to establish if these polyphenolic compounds present in the diet, known to be effective antioxidants but also endowed with several other biological activities such as protein-tyrosine kinase inhibition, interfere with GLUT4 function. In the present study, we show that three flavonoids, quercetin, myricetin and catechin-gallate, inhibit the uptake of methylglucose by adipocytes over the concentration range of 10-100 microM. These three flavonoids show a competitive pattern of inhibition, with K(i)=16, 33.5 and 90 microM respectively. In contrast, neither catechin nor gallic acid inhibit methylglucose uptake. To obtain a better understanding of the interaction among GLUT4 and flavonoids, we have derived a GLUT4 three-dimensional molecular comparative model, using structural co-ordinates from a GLUT3 comparative model and a mechanosensitive ion channel [PDB (Protein Data Bank) code 1MSL] solved by X-ray diffraction. On the whole, the experimental evidence and computer simulation data favour a transport inhibition mechanism in which flavonoids and GLUT4 interact directly, rather than by a mechanism related to protein-tyrosine kinase and insulin signalling inhibition. Furthermore, the results suggest that GLUT transporters are involved in flavonoid incorporation into cells.
Strobel
Pablo
P
Molecular Nutrition Laboratory, Faculty of Biological Sciences, Universidad Católica de Chile, Casilla 114-D, Santiago, Chile. pstrobel@bio.puc.cl
Allard
Claudio
C
Perez-Acle
Tomás
T
Calderon
Rosario
R
Aldunate
Rebeca
R
Leighton
Federico
F
D019325:3-O-Methylglucose / Q000378:metabolism; D017667:Adipocytes / Q000187:drug effects* / Q000378:metabolism*; D000818:Animals; D001667:Binding, Competitive / Q000187:drug effects; D001692:Biological Transport / Q000187:drug effects; D002392:Catechin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D003198:Computer Simulation; D005419:Flavonoids / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D051275:Glucose Transporter Type 4; D007700:Kinetics; D008958:Models, Molecular; D015394:Molecular Structure; D009004:Monosaccharide Transport Proteins / Q000737:chemistry / Q000378:metabolism; D009124:Muscle Proteins / Q000737:chemistry / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D011487:Protein Conformation; D011794:Quercetin / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D051381:Rats; D013816:Thermodynamics; D014443:Tyrosine / Q000378:metabolism
D005419:Flavonoids; D051275:Glucose Transporter Type 4; D009004:Monosaccharide Transport Proteins; D009124:Muscle Proteins; C495694:Slc2a4 protein, rat; D019325:3-O-Methylglucose; D014443:Tyrosine; C040015:myricetin; C417939:catechin gallate; D002392:Catechin; D011794:Quercetin; D005947:Glucose